ID24333A - Proses untuk perlindungan seseorang terhadap kontaminasi yaitu sebagai akibat dari pemakaian secara oral yang tidak benar komponen-komponen toksik dari sistim terapetik transdermal, dan juga sistim terapetik transdermal yang mengandung denaturan - Google Patents

Proses untuk perlindungan seseorang terhadap kontaminasi yaitu sebagai akibat dari pemakaian secara oral yang tidak benar komponen-komponen toksik dari sistim terapetik transdermal, dan juga sistim terapetik transdermal yang mengandung denaturan

Info

Publication number
ID24333A
ID24333A IDW20000399A ID20000399A ID24333A ID 24333 A ID24333 A ID 24333A ID W20000399 A IDW20000399 A ID W20000399A ID 20000399 A ID20000399 A ID 20000399A ID 24333 A ID24333 A ID 24333A
Authority
ID
Indonesia
Prior art keywords
doesn
someone
contamination
true
protection
Prior art date
Application number
IDW20000399A
Other languages
English (en)
Indonesian (id)
Inventor
Frank Becher
Ann-Katrin Klink
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of ID24333A publication Critical patent/ID24333A/id

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Anesthesiology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electrotherapy Devices (AREA)
  • Electrolytic Production Of Non-Metals, Compounds, Apparatuses Therefor (AREA)
  • Radiation-Therapy Devices (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
IDW20000399A 1997-10-01 1998-09-18 Proses untuk perlindungan seseorang terhadap kontaminasi yaitu sebagai akibat dari pemakaian secara oral yang tidak benar komponen-komponen toksik dari sistim terapetik transdermal, dan juga sistim terapetik transdermal yang mengandung denaturan ID24333A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19743484A DE19743484C1 (de) 1997-10-01 1997-10-01 Transdermales therapeutisches System mit Schutz vor oraler Applikation und Verfahren zum Schutz einer Person vor Kontamination infolge unzulässiger oraler Applikation toxischer Inhaltsstoffe eines transdermalen therapeutischen Systems

Publications (1)

Publication Number Publication Date
ID24333A true ID24333A (id) 2000-07-13

Family

ID=7844345

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000399A ID24333A (id) 1997-10-01 1998-09-18 Proses untuk perlindungan seseorang terhadap kontaminasi yaitu sebagai akibat dari pemakaian secara oral yang tidak benar komponen-komponen toksik dari sistim terapetik transdermal, dan juga sistim terapetik transdermal yang mengandung denaturan

Country Status (23)

Country Link
EP (1) EP1019032B1 (no)
JP (2) JP4755338B2 (no)
KR (1) KR100552102B1 (no)
AT (1) ATE228356T1 (no)
AU (1) AU759609B2 (no)
CA (1) CA2305432C (no)
DE (2) DE19743484C1 (no)
DK (1) DK1019032T3 (no)
ES (1) ES2188021T3 (no)
HK (1) HK1029919A1 (no)
HU (1) HU226644B1 (no)
ID (1) ID24333A (no)
IL (1) IL134479A (no)
MY (1) MY116425A (no)
NO (2) NO319163B1 (no)
NZ (1) NZ503643A (no)
PL (1) PL193066B1 (no)
PT (1) PT1019032E (no)
SK (1) SK3332000A3 (no)
TR (1) TR200000461T2 (no)
TW (1) TW431894B (no)
WO (1) WO1999016428A1 (no)
ZA (1) ZA988904B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19743484C1 (de) * 1997-10-01 1999-01-28 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit Schutz vor oraler Applikation und Verfahren zum Schutz einer Person vor Kontamination infolge unzulässiger oraler Applikation toxischer Inhaltsstoffe eines transdermalen therapeutischen Systems
GB0026137D0 (en) * 2000-10-25 2000-12-13 Euro Celtique Sa Transdermal dosage form
US7867511B2 (en) * 2004-01-23 2011-01-11 Travanti Pharma Inc. Abuse potential reduction in abusable substance dosage form
DE102004019916A1 (de) * 2004-04-21 2005-11-17 Grünenthal GmbH Gegen Missbrauch gesichertes wirkstoffhaltiges Pflaster
CN112823191A (zh) * 2018-10-17 2021-05-18 日荣新化株式会社 粘合片及其制造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8804164D0 (en) * 1988-02-23 1988-03-23 Tucker J M Bandage for administering physiologically active compound
US5236714A (en) * 1988-11-01 1993-08-17 Alza Corporation Abusable substance dosage form having reduced abuse potential
US5149538A (en) * 1991-06-14 1992-09-22 Warner-Lambert Company Misuse-resistive transdermal opioid dosage form
DE4342174C1 (de) * 1993-12-10 1995-05-11 Lohmann Therapie Syst Lts Transdermales therapeutisches System sowie ein Verfahren zur Herstellung eines transdermalen therapeutischen Systems zur kombinierten transdermalen Anwendung von Physostigmin und Scopolamin für die Prophylaxe und zur Vorbehandlung einer Vergiftung durch hochtoxische phosphororganische Nervengifte, insbesondere Soman und seine Verwendung
DE19743484C1 (de) * 1997-10-01 1999-01-28 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit Schutz vor oraler Applikation und Verfahren zum Schutz einer Person vor Kontamination infolge unzulässiger oraler Applikation toxischer Inhaltsstoffe eines transdermalen therapeutischen Systems

Also Published As

Publication number Publication date
EP1019032B1 (de) 2002-11-27
NO20001691L (no) 2000-03-31
AU759609B2 (en) 2003-04-17
JP2001517695A (ja) 2001-10-09
ATE228356T1 (de) 2002-12-15
PL339736A1 (en) 2001-01-02
HUP0003476A3 (en) 2001-04-28
HU226644B1 (en) 2009-05-28
ES2188021T3 (es) 2003-06-16
NO20001492D0 (no) 2000-03-22
TW431894B (en) 2001-05-01
CA2305432C (en) 2007-04-03
KR20010030886A (ko) 2001-04-16
SK3332000A3 (en) 2000-11-07
HK1029919A1 (en) 2001-04-20
TR200000461T2 (tr) 2000-09-21
PL193066B1 (pl) 2007-01-31
NO319163B1 (no) 2005-06-27
HUP0003476A2 (hu) 2001-02-28
PT1019032E (pt) 2003-04-30
DE59806468D1 (de) 2003-01-09
MY116425A (en) 2004-01-31
NO20001691D0 (no) 2000-03-31
CA2305432A1 (en) 1999-04-08
DE19743484C1 (de) 1999-01-28
NO20001492L (no) 2000-03-22
WO1999016428A1 (de) 1999-04-08
IL134479A (en) 2005-07-25
AU9626598A (en) 1999-04-23
IL134479A0 (en) 2001-04-30
DK1019032T3 (da) 2003-03-10
JP4755338B2 (ja) 2011-08-24
ZA988904B (en) 1999-04-12
NZ503643A (en) 2003-05-30
JP2009035561A (ja) 2009-02-19
KR100552102B1 (ko) 2006-02-13
EP1019032A1 (de) 2000-07-19

Similar Documents

Publication Publication Date Title
BR0008176A (pt) Derivados anti-convulsivantes úteis no tratamento de cefaléias em cacho
ID29552A (id) Senyawa-senyawa triazola dan penggunaannya
BR9710993A (pt) Derivados anticonvulsivos úteis no tratamento de esclerose lateral amiotrófica (als)
PL337329A1 (en) Oxazolydinone based antibacterial agents comprising a thiocarbonyl functional group
NZ331189A (en) Method of detection of influenza virus using neuraminidase binders
ATE295347T1 (de) Stoffe und zusammensetzungen für die verabreichung aktiver substanzen
FI953442A0 (fi) Gonadotropiinia sisältäviä pakastekuivattuja pallosia
NO965516L (no) Sterolderivater anvendt til regulering av meiose
PH31335A (en) Naphthalamides as central nervous system agent.
DE69801577D1 (de) Staubkontrollzusammensetzung
BR9913072A (pt) Sistemas de anel azacìclico, composição farmacêutica, e, processo para induzir a analgesia
ID29295A (id) Senyawa pirimidinona, komposisi farmasi yang mengandung senyawa tersebut dan proses penyediaannya senyawa tersebut
DE69729183T2 (de) Als entzündungshemmende mittel nützliche dihydrobenzofurane und verwandte verbindungen
ID24333A (id) Proses untuk perlindungan seseorang terhadap kontaminasi yaitu sebagai akibat dari pemakaian secara oral yang tidak benar komponen-komponen toksik dari sistim terapetik transdermal, dan juga sistim terapetik transdermal yang mengandung denaturan
ATE272648T1 (de) Glycokonjugate von 20(s)-camptothecin
HUP0202729A2 (hu) Ösztramusztin-foszfátot és aminosavakat tartalmazó, parenteralis felhasználásra szolgáló készítmények
DE59811656D1 (en) Kombinationspräparat aus 2-methylthiazolidin-2,4-dicarbonsäure und paracetamol
GEP20032975B (en) Echinocandin Derivatives, Preparation Method and Pharmaceutical Composition
ES2170377T3 (es) Composicion que contiene quitosana.
HUT75529A (en) Use of dimeticone for treating constipation
ATE220535T1 (de) Zahnputzmittel als granulat
AP9600780A0 (en) Process for the preparation of peroxetine hydrochloride anhydrate and its use as therapeutic agent.